Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Data collection capabilities of a new non-invasive monitoring system for patients with advanced multiple sclerosis.
I-BET151 selectively regulates IL-6 production.
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India.
Toll like receptors: a new hope on the horizon to treat multiple sclerosis.
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
A multicomponent T2 relaxometry algorithm for myelin water imaging of the brain.
A longitudinal model for disease progression was developed and applied to multiple sclerosis.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
Progressive MS: from pathophysiology to drug discovery.
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
The zebrafish as a gerontology model in nervous system aging, disease, and repair.
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
Ultra-high-field MR imaging in multiple sclerosis.
Galectin-9 is Up-regulated in Astrocytes by TNF and Promotes Encephalitogenic T-cell Apoptosis.
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.
Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
[Multiple sclerosis: new drugs and their molecular targets].
Sexual problems among women with multiple sclerosis.
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Neuroimaging evidence of deficient axon myelination in Wolfram syndrome.
Pages
« first
‹ previous
…
478
479
480
481
482
483
484
485
486
…
next ›
last »